Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals ARWR
$ 19.68 0.9%

Annual report 2024
added 11-26-2024

report update icon

Arrowhead Pharmaceuticals Financial Ratios 2011-2024 | ARWR

Annual Financial Ratios Arrowhead Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-4.2 -15.1 -17.2 -32.4 -94.1 55.3 -19.1 -7.8 -4.4 -3.2 -5.4 -5.4 -1.1 -11.9

P/S

714.5 12.9 12.4 33.0 90.4 22.3 64.6 8.6 2261.5 773.3 1804.9 574.7 164.4 126.1

EPS

-5 -1.9 -1.7 -1.4 -0.8 0.7 -0.7 -0.5 -1.3 -1.6 -1.2 -1.3 -1.9 -0.4

EV (Enterprise Value)

2.43 B 2.98 B 2.91 B 4.38 B 7.81 B 3.64 B 1.03 B 268 M 306 M 237 M 200 M 159 M 28.5 M 33.2 M

EBITDA per Share

-4.88 -1.82 -1.61 -1.37 -0.88 0.699 -0.613 -0.437 -1.25 -1.63 -1.06 -0.897 -1.74 -1.34

EV/EBITDA

-30.8 -64.5 53.9 -19.8 -7.7 -3.6 -2.3 -3.7 -6.9 -1.1 -3.2

PEG

-0.74 0.21 0.26 0.4 0.96 0.26 0.5 -0.12 -0.27 0.11 -1.4 -0.17 0.0 -0.23

P/B

2.2 4.0 4.4 6.4 15.2 15.4 10.9 3.3 3.8 2.7 1.9 6.5 2.7 3.0

P/CF

-5.5 -20.1 -22.2 26.6 -83.1 23.3 -21.4 -8.5 -5.2 -4.4 -8.5 -8.6 -1.5 -6.9

ROE %

-323.27 -75.65 -42.09 -34.45 -18.31 27.85 -57.17 -42.51 -86.00 -83.87 -35.32 -121.02 -239.82 -24.90

ROA %

-52.60 -26.81 -25.44 -19.83 -16.18 19.43 -48.79 -33.05 -63.76 -69.51 -32.07 -83.43 -127.82 -19.69

ROCE %

-58.30 -31.82 -32.27 -26.44 -19.33 24.21 -56.36 -43.36 -77.72 -82.48 -29.89 -81.39 -188.30 -73.88

Current Ratio

- - - - - 2.7 6.4 3.6 3.5 6.5 13.1 3.3 1.2 3.8

DSO

- - 8.8 14.6 3.1 1.4 7.4 0.8 172.9 - - 105.2 6126.8 1982.4

DIO

- - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - -

Operating Cycle

- - 8.8 14.7 3.1 - - - - - - - - -

Cash Conversion Cycle

- - 8.8 14.7 3.1 - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Arrowhead Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.38 -1.02 -1.24 - -0.96 0.46 -0.39 - -0.68 0.42 -0.6 - -0.29 -0.26 -0.2 -0.48 -0.13 -0.2 -0.03 0.12 0.21 -0.03 0.13 -0.12 -0.18 0.13 -0.18 -0.14 -0.07 -0.18 -0.17 -0.34 -0.32 -0.17 -0.32 -0.42 -0.27 -0.32 -0.41 -0.42 -0.22 -0.41 -0.28 -0.43 -0.23 -0.41 -0.33 -1.48 -0.71 -0.5 -0.25 -0.05 -0.25 0.4

EBITDA per Share

-1.38 -0.99 -1.24 - -0.93 0.47 -0.38 - -0.67 0.41 -0.59 - -0.29 -0.26 -0.22 -0.47 -0.15 -0.22 -0.04 0.13 0.2 -0.04 0.13 -0.09 -0.16 0.13 -0.17 -0.09 -0.06 -0.17 -0.19 -0.32 -0.31 -0.19 -0.31 -0.42 -0.26 -0.31 -0.45 -0.48 -0.24 -0.45 -0.18 -0.35 -0.23 0.07 -0.31 -1.35 -0.57 -0.41 -0.35 -0.18 -0.24 -0.5

ROE %

-187.35 -162.63 -126.26 -26.91 -42.10 -30.35 -31.00 -22.26 -29.11 -20.76 -37.77 -18.61 -26.43 -22.34 -19.34 -15.31 15.52 26.59 29.69 37.22 -31.39 -55.99 -42.34 -67.99 -35.56 -26.05 -46.04 -39.74 -49.81 -63.35 -77.71 -86.08 -85.29 -79.43 -75.14 -69.84 -60.85 -53.37 -49.44 -46.85 -83.18 -98.30 -123.40 -161.96 -270.09 -327.80 -335.23 -299.19 -1030.23 -964.64 -937.99 -888.96 -14.23 -19.43

ROA %

-66.59 -60.20 -41.62 -12.11 -12.11 7.13 7.98 2.77 -7.61 -11.68 -21.77 -12.00 -18.91 -17.45 -17.64 -13.94 9.06 17.47 20.68 24.66 -30.57 -50.36 -38.81 -57.30 -28.48 -19.80 -36.39 -29.81 -36.83 -46.68 -57.11 -66.02 -67.40 -64.29 -62.62 -59.25 -52.81 -47.12 -44.90 -42.45 -66.85 -76.78 -92.90 -111.73 -170.72 -202.79 -202.23 -182.72 -802.70 -765.81 -753.53 -715.66 -11.45 -15.64

ROCE %

-76.00 -67.53 -47.18 -13.64 -29.02 -30.24 -28.87 -20.64 -26.55 -17.08 -29.79 -16.33 -26.74 -23.94 -23.26 -19.13 -4.92 5.52 8.29 14.52 -0.48 -23.77 -10.88 -34.58 -35.32 -26.03 -53.08 -48.50 -57.70 -69.81 -68.18 -73.78 -74.22 -69.13 -71.22 -68.41 -59.86 -53.59 -51.69 -43.28 -56.59 -70.22 -78.66 -116.17 -216.49 -250.30 -265.99 -242.21 -166.66 -124.90 -115.96 -51.11 -13.08 -29.84

Current Ratio

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

- - - - 206.2 34.2 33.4 - 1.9 0.4 17.3 - 10.9 26.8 21.1 10.1 2.8 4.7 3.1 1.4 1.4 5.9 4.6 2.6 41.1 33.5 2.8 0.7 0.7 1.7 1.4 219.0 172.9 0.8 - - - 132.4 33.9 - - 20.0 156.4 156.4 156.4 198.4 35.8 8.3 17.9 2.7 - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - 112.0 - 108.7 99.0 170.0 90.9 271.4 186.9 120.1 44.7 128.6 128.3 124.2 30.8 95.9 45.9 39.2 21.9 66.3 44.0 47.2 16.1 48.4 44.6 44.6 48.4 148.6 -

Operating Cycle

- - - - 206.2 34.2 33.4 - 1.9 0.4 17.3 - 10.9 26.8 21.1 10.1 2.8 4.7 3.1 1.4 1.4 5.9 4.6 2.6 41.1 33.5 2.8 0.7 0.7 1.7 1.4 219.0 172.9 0.8 - - - 132.4 33.9 - - 20.0 156.4 156.4 156.4 198.4 35.8 8.3 17.9 2.7 - - - -

Cash Conversion Cycle

- - - - 206.2 34.2 33.4 - 1.9 0.4 17.3 - 10.9 26.8 21.1 10.1 2.8 4.7 3.1 1.4 1.4 5.9 4.6 2.6 41.1 33.5 -109.2 0.7 -108.1 -97.3 -168.6 128.1 -98.5 -186.2 -120.1 -44.7 -128.6 4.1 -90.2 -30.8 -95.9 -25.9 117.2 134.6 90.2 154.4 -11.5 -7.8 -30.6 -41.9 -44.6 -48.4 -148.6 -

All numbers in USD currency